Article Sidebar
Published:
Apr 8, 2016Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Inhibition of Caspase-3, -6, -8 and -9 Expression in Rats with Acute Spinal Cord Injury by Cantharidin Treatment
Abstract
Purpose: To demonstrate the anti-apoptotic effects of cantharidin in mice with acute spinal cord injury (ASCI).
Methods: In total, 30 male Sprague-Dawley mice were divided into three groups of 10 animals each. ASCI was induced in two of the groups using a modified Allen's method, consisting of treatment with 10 mg/kg body weight cantharidin after injury, and sacrifice on days 2, 5, 10, 20 and 30 to extract the spinal cord. The activity levels of caspase-3, -6, -8, and -9 were determined spectrophotometrically at 455 nm with a microplate reader.
Results: The results showed that cantharidin treatment caused a significant reduction in the expression levels of all four caspases – caspase-3, -6, -8, and -9 – compared with the untreated groups. Two hours after ASCI, caspase levels in the cantharidin-treated group increased, reaching maximum after day 5, but were significantly lower than in the untreated group. The expression levels of caspases in the cantharidin-treated group were similar to those in the control group on days 20 and 30 following ASCI (p> 0.05).
Conclusion: Cantharidin treatment exerts an anti-apoptotic effect against secondary spinal cord injury (SCI) by suppressing caspase activity. Thus, cantharidin may be suitable for the treatment of secondary SCI.
Keywords: Cantharidin, Caspase, Anti-apoptotic, Inhibition, Regeneration
